A Comparative Study between Hyaluronic Acid and Corticosteroids for the Treatment of the Greater Trochanteric Pain Syndrome

Abstract Full-Text HTML XML Download Download as PDF (Size:667KB) PP. 57-61
DOI: 10.4236/ojra.2015.53010    3,465 Downloads   4,055 Views   Citations

ABSTRACT

Objective: To date, there are no studies addressing the efficacy of hyaluronic acid (HA) injections at the trochanteric bursa in patients with greater trochanteric pain syndrome (GTPS). The objective of the study was to compare the efficacy and safety of HA to corticosteroid injections for the treatment of the GTPS. Methods: This prospective, randomized, two-arm trial involved 47 patients with unilateral or bilateral GTPS. Patients received an intra-bursal injection of 40 mg triamcinolone acetonide plus 1mL lidocaine, or of 60 mg HA. Patients completed visual analog scales (VAS) and Likert scales to evaluate interference of pain with daily activity, recovery from pain, and treatment satisfaction. A non-inferiority analysis was also performed. Results: Mean VAS score for pain significantly decreased comparing baseline with 1, 3 and 6 months in both treatment groups. VAS score for pain on palpation was also significantly lower than baseline in both arms. No significant differences were found between groups. Analysis of Likert scales at the sixth month didn’t detect statistically significant differences between treatment groups. The non-inferiority analysis showed that the treatment with HA was non-inferior to corticosteroids. No secondary adverse effects were found among the patients of both groups during the follow-up. Conclusions: The treatment with HA has demonstrated to be non-inferior to corticosteroids after 6 months of follow-up in patients with GTPS. Therefore, the treatment with HA may be considered an effective alternative therapeutic strategy to reduce pain in patients in whom the treatment with corticosteroids, or other therapies, have been unsuccessful or contraindicated.

Cite this paper

Pereira, A. , López, B. and Rodriguez de la Serna, A. (2015) A Comparative Study between Hyaluronic Acid and Corticosteroids for the Treatment of the Greater Trochanteric Pain Syndrome. Open Journal of Rheumatology and Autoimmune Diseases, 5, 57-61. doi: 10.4236/ojra.2015.53010.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Williams, B.S. and Cohen, S.P. (2009) Greater Trochanteric Pain Syndrome: A Review of Anatomy, Diagnosis and Treatment. Anesthesia Analgesia, 108, 1662-1670.
http://dx.doi.org/10.1213/ane.0b013e31819d6562
[2] Segal, N.A., Felson, O.T., Torner, J.C., Zhu, Y.Y., Curtis, J.R., Niu, J.B. and Nevitt, M.C. (2007) Greater Trochanteric Pain Syndrome Epidemiology and Associated Factors. Archives of Physical Medicine and Rehabilitation, 88, 988-992.
http://dx.doi.org/10.1016/j.apmr.2007.04.014
[3] Lievense, A., Bierma-Zeinstra, S., Schouten, B., Bohnen, A., Verhaar, J. and Koes, B. (2005) Prognosis of Trochanteric Pain in Primary Care. British Journal of General Practice, 55, 199-204.
[4] Gordon, E.J. (1961) Trochanteric Bursitis and Tendinitis. Clinical Orthopaedics, 20, 193-202.
[5] Ege Rasmussen, K.-J., Fano, N. (1985) Trochanteric Bursitis: Treatment by Corticosteroid Injection. Scandinavian Journal of Rheumatology, 14, 417-420.
http://dx.doi.org/10.3109/03009748509102047
[6] Shbeeb, M.I., O’Duffy, J.D., Michet Jr, C.J., O’Fallon, W.M. and Matteson, E.L. (1996) Evaluation of Glucocorticosteroid Injection for the Treatment of Trochanteric Bursitis. Journal of Rheumatology, 23, 2104-2106.
[7] Cohen, S.P., Narvaez, J.C., Lebovits, A.H. and Stojanovic, M.P. (2005) Corticosteroid Injections for Trochanteric Bursitis: Is Fluoroscopy Necessary? A Pilot Study. British Journal of Anaesthesia, 94, 100-106.
http://dx.doi.org/10.1093/bja/aei012
[8] Swezey, R.L. (1976) Pseudo-Radiculopathy in Subacute Trochanteric Bursitis of the Subgluteus Maximus Bursa. Archives of Physical Medicine and Rehabilitation, 57, 387-390.
[9] Habib, G.S. and Miari, W. (2011) The Effect of Intra-Articular Triamcinolone Preparations on Blood Glucose Levels in Diabetic Patients: A Controlled Study. Journal of Clinical Rheumatology, 17, 302-305.
http://dx.doi.org/10.1097/RHU.0b013e31822acd7c
[10] Jordan, K.M., Arden, N.K., Doherty, M., Bannwarth, B., Bijlsma, J.W., Dieppe, P., et al. (2003) EULAR Recommendations 2003: An Evidence Based Approach to the Management of Knee Osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Annals of the Rheumatic Diseases, 62, 1145-1155.
http://dx.doi.org/10.1136/ard.2003.011742
[11] Gorelick, L., Rozano-Gorelick, A., Robinson, D., Marcus, O., Joubran, S. and Ram, E. (2013) Treatment of Hip Trochanteric Bursitis Using Hyaluronate Injections. Open Journal of Rheumatology and Autoimmune Diseases, 3, 125-129.
http://dx.doi.org/10.4236/ojra.2013.32019
[12] Walker, P., Kannangara, S., Bruce, W.J., Michael, D. and Van der Wall, H. (2007) Lateral Hip Pain: Does Imaging Predict Response to Localized Injection? Clinical Orthopaedics and Related Research, 457, 144-149.
[13] Chang, W.H., Im, S.H., Ryu, J.A., Lee, S.C. and Kim, J.S. (2009) The Effects of Scapulothoracic Bursa Injections in Patients with Scapular Pain: A Pilot Study. Archives of Physical Medicine and Rehabilitation, 90, 279-284.
http://dx.doi.org/10.1016/j.apmr.2008.07.027
[14] Dixon, A.S., Jacoby, R.K., Berry, H. and Halmiton, E.B. (1988) Clinical Trial of Intraarticular Injection of Sodium Hyaluronate in Patients with Osteoarthritis of the Knee. Current Medical Research & Opinion, 11, 205-213.
http://dx.doi.org/10.1185/03007998809114237

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.